Author

Nicholas Pudjihartono

Department of Biochemistry, School of Biomedical Sciences University of Otago Dunedin New ZealandPrimary ORCID profile (0000-0003-3258-0014 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nicholas PudjihartonoiD1 paper · University of Auckland

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1

Frequent Co-Authors

Adam J. MiddletoniD· 1 shared Catherine L. DayiD· 1 shared Jeffery M. R. B. McAlpine· 1 shared Jingyi Zhu· 1 shared Joan Teyra· 1 shared Michael J. CurrieiD· 1 shared Renwick C. J. DobsoniD· 1 shared Sachdev S. Sidhu· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adam J. MiddletonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structural and biophysical characterisation of ubiquitin variants that specifically inhibit the ubiquitin conjugating enzyme Ube2d2

Jeffery M. R. B. McAlpine, Jingyi Zhu, Nicholas Pudjihartono, Joan Teyra, Michael J. Currie, Zachary D. Tillett, Renwick C. J. Dobson, Sachdev S. Sidhu, Catherine L. Day, Adam J. Middleton

The paper identifies ubiquitin variants that inhibit Ube2d2, showing structural and biophysical properties that suggest potential for developing selective E2 enzyme inhibitors.

bioRxiv · Mar 10, 2024Biochemistry